Treatment News : New Anti-HIV Compounds Discovered

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » December 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

December 27, 2013

New Anti-HIV Compounds Discovered

Researchers at the University of Minnesota have identified a series of novel compounds that combat HIV and may one day lead to new options for antiretroviral treatment. Publishing their findings in the Journal of Virology, the investigators discovered five compounds called ribonucleoside analogs that in laboratory studies either blocked replication of HIV at the point in its life cycle called reverse transcription or that caused the virus to mutate into extinction.

“It’s a counterintuitive finding,” said Louis Mansky, PhD, a virologist at the University of Minnesota and one of the study’s authors, said in a release. “These ribonucleoside analogs were not generally thought to be associated with affecting HIV DNA synthesis—a critical step in virus replication. We don’t yet know all the details for how these particular compounds stop the virus in its path.”

If research pans out, these findings may lead to new, cost-effective HIV treatments and a means to combat resistance to today’s antiretrovirals. Ribonucleoside analogs are less expensive to produce than the deoxyribonucleoside analogs currently in use and for which they might provide an alternative.

To read the study abstract, click here.

To read a release on the study, click here.

Search: University of Minnesota, HIV, novel compounds, Journal of Virology, ribonucleoside analogs, Louis MAnsky, deosyribonucleoside.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    chrisf
    san jose
    California


    soy_Ric
    Rochester
    New York


    latinpozdallas
    Dallas
    Texas


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.